• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

    1.940 +0.030 (+1.57%)
    Streaming Delayed Price Updated: 3:59 PM EST, Dec 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 119,638
    Open 1.910
    Bid (Size) 1.930 (400)
    Ask (Size) 1.950 (600)
    Prev. Close 1.910
    Today's Range 1.910 - 1.990
    52wk Range 0.6200 - 2.540
    Shares Outstanding 124,094,390
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Which stocks are moving on Monday? ↗
    Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report. 
    Via Chartmill
    News headline image
    Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire

    Performance

    YTD
    +14.8%
    +14.8%
    1 Month
    -2.0%
    -2.0%
    3 Month
    +129.6%
    +129.6%
    6 Month
    +165.8%
    +165.8%
    1 Year
    +16.2%
    +16.2%

    More News

    Read More
    News headline image
    Nautilus (NAUT) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Earnings Scheduled For October 28, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For July 31, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For April 29, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For February 27, 2025 ↗
    Via Benzinga
    News headline image
    Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    News headline image
    Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    These stocks are moving in today's pre-market session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports First Quarter 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Nautilus Biotechnology, Inc. - Common Stock publicly traded?
    Yes, Nautilus Biotechnology, Inc. - Common Stock is publicly traded.
    What exchange does Nautilus Biotechnology, Inc. - Common Stock trade on?
    Nautilus Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Nautilus Biotechnology, Inc. - Common Stock?
    The ticker symbol for Nautilus Biotechnology, Inc. - Common Stock is NAUT on the Nasdaq Stock Market
    What is the current price of Nautilus Biotechnology, Inc. - Common Stock?
    The current price of Nautilus Biotechnology, Inc. - Common Stock is 1.940
    When was Nautilus Biotechnology, Inc. - Common Stock last traded?
    The last trade of Nautilus Biotechnology, Inc. - Common Stock was at 12/31/25 03:59 PM ET
    What is the market capitalization of Nautilus Biotechnology, Inc. - Common Stock?
    The market capitalization of Nautilus Biotechnology, Inc. - Common Stock is 240.74M
    How many shares of Nautilus Biotechnology, Inc. - Common Stock are outstanding?
    Nautilus Biotechnology, Inc. - Common Stock has 241M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.